Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors
about
The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and AgingRICTOR polymorphisms affect efficiency of platinum-based chemotherapy in Chinese non-small-cell lung cancer patients.Endogenous transmembrane protein UT2 inhibits pSTAT3 and suppresses hematological malignancyTargeted reduction of the EGFR protein, but not inhibition of its kinase activity, induces mitophagy and death of cancer cells through activation of mTORC2 and Akt.Mammalian target of rapamycin complex 2 regulates muscle glucose uptake during exercise in mice.Analysis of L1-chimeric transcripts derived from bidirectional promoter of human-specific L1
P2860
Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors
@en
Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors
@nl
type
label
Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors
@en
Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors
@nl
prefLabel
Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors
@en
Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors
@nl
P2093
P2860
P1433
P1476
Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors
@en
P2093
Andrew A Lane
David T Scadden
Demetrios Kalaitzidis
Dongjun Lee
Marc H G P Raaijmakers
Scott A Armstrong
Stephen M Sykes
Ying-Hua Wang
Youmna Kfoury
P2860
P304
P356
10.1016/J.STEMCR.2014.08.011
P577
2014-09-25T00:00:00Z